Time Interval for Endoscopic Variceal Ligation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01291277 |
|
Recruitment Status :
Completed
First Posted : February 8, 2011
Results First Posted : December 26, 2016
Last Update Posted : February 13, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Variceal Bleeding | Device: Endoscopic Variceal Ligation | Phase 4 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 90 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Appropriate Time Interval for Repeat Sessions of Endoscopic Ligation for the Eradication of Esophageal Varices |
| Study Start Date : | August 2008 |
| Actual Primary Completion Date : | September 2015 |
| Actual Study Completion Date : | December 2015 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Ligation: 1-week interval
Endoscopic variceal ligation performed at 1-week intervals
|
Device: Endoscopic Variceal Ligation
Ligation of esophageal varices
Other Name: variceal banding |
|
Active Comparator: Ligation 2-week interval
Endoscopic variceal ligation performed at 2-week intervals
|
Device: Endoscopic Variceal Ligation
Ligation of esophageal varices
Other Name: variceal banding |
- Proportion of Patients With Eradication of Esophageal Varices [ Time Frame: At 4 weeks ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients who presented with acute upper GI bleeding due to esophageal varices and underwent successful endoscopic variceal ligation.
- Patients who would normally receive repeat endoscopic ligation therapy to eradicate varices.
Exclusion Criteria:
- Persistent bleeding despite endoscopic and medical therapy
- Platelet count < 40,000
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01291277
| United States, California | |
| L.A. County + U.S.C. Medical Center | |
| Los Angeles, California, United States, 90033 | |
| Principal Investigator: | Loren Laine, M.D. | University of Southern California |
| Responsible Party: | Loren Laine, Investigator, University of Southern California |
| ClinicalTrials.gov Identifier: | NCT01291277 |
| Other Study ID Numbers: |
HS-08-00172 |
| First Posted: | February 8, 2011 Key Record Dates |
| Results First Posted: | December 26, 2016 |
| Last Update Posted: | February 13, 2017 |
| Last Verified: | December 2016 |
|
gastrointestinal hemorrhage esophageal varices gastrointestinal endoscopy ligation |

